{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["4"],"submitter":["Neven P"],"journal":["Translational breast cancer research : a journal focusing on translational research in breast cancer"],"pagination":["31"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11093079"],"repository":["biostudies-literature"],"pubmed_title":["Navigating next-generation HR<sup>+</sup>/HER2<sup>-</sup> metastatic breast cancer therapies: a critical commentary on abemaciclib <i>vs.</i> tucidinostat after palbociclib progression."],"pmcid":["PMC11093079"],"pubmed_authors":["Van Houdt M","Dullens L","Neven P","Deblander A","Wildiers H","Han S","Van Herck Y"],"additional_accession":[]},"is_claimable":false,"name":"Navigating next-generation HR<sup>+</sup>/HER2<sup>-</sup> metastatic breast cancer therapies: a critical commentary on abemaciclib <i>vs.</i> tucidinostat after palbociclib progression.","description":null,"dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2026-06-03T03:50:43.851Z","creation":"2026-04-24T03:09:31.959Z"},"accession":"S-EPMC11093079","cross_references":{"pubmed":["38751459"],"doi":["10.21037/tbcr-23-41"]}}